Home/Filings/4/0001847903-25-000041
4//SEC Filing

CHAO DAVID M 4

Accession 0001847903-25-000041

CIK 0001847903other

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 4:47 PM ET

Size

11.3 KB

Accession

0001847903-25-000041

Insider Transaction Report

Form 4
Period: 2025-03-17
CHAO DAVID M
Chief Administrative Officer
Transactions
  • Sale

    Ordinary Shares

    2025-03-17$17.50/sh1,522$26,630225,007 total
  • Exercise/Conversion

    Share Option (right to buy)

    2025-03-173,500111,500 total
    Exercise: $3.85Exp: 2033-02-01Ordinary Shares (3,500 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2025-03-17$3.85/sh+3,500$13,475232,007 total
  • Sale

    Ordinary Shares

    2025-03-17$17.08/sh5,478$93,576226,529 total
Footnotes (5)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2024.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.45 to $17.445, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.455 to $17.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F5]1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 1, 2023.

Issuer

Centessa Pharmaceuticals plc

CIK 0001847903

Entity typeother

Related Parties

1
  • filerCIK 0001861871

Filing Metadata

Form type
4
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 4:47 PM ET
Size
11.3 KB